Clinical Trial Update: Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating intra-tumoral NIS measles virus with atezolizumab in recurrent non-small cell lung cancer; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• NIS Measles Virus (intra-tumoral) (NIS measles virus)

Snippet

Sponsor: Vyriad, Inc. | Conditions: Recurrent Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2023-07-21